What Mistakes to Avoid When Playing Biotech

The Life Sciences Report | |

The stock market volatility is causing some investors to rethink their biotech investments.

7 Micro-Cap Biotech Stocks with Massive Potential

The Life Sciences Report | |

Biotechnology can be daunting to comprehend, but understanding is critical to successful investment. BioWatch News Founder Alan Leong has a nose for growth names, and his goal is to make their

Biotech Stocks With Considerable Upside Potential

The Life Sciences Report | |

Everybody knows that biotech ideas can become huge gainers for investors, but understanding the technology platforms, the unmet needs and the valuations can be daunting, especially in spaces where

Conatus (CNAT) Surges Amid Hepatitis C Fervor

Remy Merritt | |

Conatus Pharmaceuticals (CNAT) continues the trend of huge pharmaceutical and biotechnology movers this week, peaking on June 11 at an intraday high of $9.87 a share. The past week has seen huge

26th Annual ROTH Conference Opens with Panel Discussion on Affordable Care Act

Joel Anderson | |

The 26th Annual ROTH Conference kicked off on Sunday with a panel presentation exploring how the health care industry might be affected by the Affordable Care Act. While not a subject that’s

Intercept Pharmaceuticals (ICPT) Sees Pullback from Record Gains

Joel Anderson | |

Intercept Pharmaceuticals (ICPT) continued its wild, roller-coaster ride on Tuesday, with a second-straight day of major losses. Intercept made news last week after its treatment for fatty liver

Intercept Pharmaceuticals (ICPT) Continues to Soar

Joel Anderson | |

Shares in biopharmaceutical company Intercept Pharmaceuticals (ICPT) spiked over 70 percent Friday before pulling pack to gains of around 60 percent, one day after shares soared more than 280

DJIA, NASDAQ Edge Lower as S&P Gains on Financials and Services

Michael Teague | |

Stocks were mostly lower at the conclusion of Thursday’s trading session, as Wall Street braces itself for what could be more good economic data in the form of Friday’s December jobs

IPO Report: Conatus Pharmaceuticals (CNAT)

Francis Gaskins | |

Update:  7-23, hot sector, worth a shot on the IPO Based in San Diego, CA, Conatus Pharmaceuticals (CNAT) scheduled a $55 million IPO with a market capitalization of $161 million at a price

Sequester Looms, Does Anyone Care?

George Brooks | |

Congress returns today to face the sequester deadline, a mere 10 days away. Automatic spending cuts of $85 billion through September 30 are expected to kick in at varying times after March 1, if

Discover: Trending Events

United Nations
Blockchain for Europe
Humanity 2.0
World Economic Forum